Codon Capital
Funding rounds backed by Codon Capital.
- Funding disclosed in full
- $107M
- Median round
- $107M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| EpiBiologics Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo... | $107MSeries B | BiotechUnited States |